Bluebird Bio to Downsize in Move to Assembly Row
Cambridge-based Bluebird Bio is leaving pricey Kendall Square for Somerville’s Assembly Row in a real estate deal that’s expected to save the company $120 million over the next six years.
by Steve Adams | Nov 5, 2021
Cambridge-based Bluebird Bio is leaving pricey Kendall Square for Somerville’s Assembly Row in a real estate deal that’s expected to save the company $120 million over the next six years.
We're sorry, it appears you don't have the proper subscription to view this page. Please click the button below to purchase or renew your subscription and gain access to this content.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
It appears someone has logged in to your account from another device. Please click the button below to log back in on this device, and terminate all other sessions.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
Already have a subscription?
Need a subscription?
Just looking for the headlines?
If you need assistance with your subscription, please visit our customer service form or email customerservice@thewarrengroup.com.